Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

Cairo University (CU)

Status and phase

Completed

Phase 2

Conditions

Geriatric

Performance

Treatments

Drug: Zirconomer Improved

Drug: Ketac Molar quick Aplicap

Study type

Interventional

Funder types

Other

Identifiers

NCT04298151

Zirconia GI Conventional GI

Details and patient eligibility

About

This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities

Full description

This study will be conducted to determine the clinical performance of the Zirconia reinforced glass ionomer restorations ( Zirconomer improved) under stress bearing posterior area (class I or claa II cavities) in geriatric population in comparison to Conventional viscous glass ionomer restorations (Ketac molar quick Aplicap) using the modified United States Public Health Service (USPHS) criteria

P: Geriatric Patients with posterior Caries lesions I: Zirconia reinforced GI (Zirconomer Improved) C: Conventional viscous GI, (Ketac Molar quick Aplicap) O: The Clinical performance of the Glass Ionomer restorations Using USPHS Criteria

Enrollment

28 patients

Sex

All

Ages

60 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age range 60-80 years
Geriatric patients with Class I or II Posterior carious lesions.
Males or Females.
Pulp asymptomatic vital carious posterior teeth.
Co-operative patients approving to participate in the trial.

Exclusion criteria

Age range less than 60 years.
Disabilities.
Deep extensive carious cavities that may lead to fracture of the tooth or pulpal affection.
Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
Heavy smoking.
Lack of compliance.